Lifestance Health Group (LFST)
NASDAQ:LFST
Want to see LFST full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.02Last Year’s EPS
-0.01Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a strong operational and financial quarter with robust revenue growth (+21%), substantial adjusted EBITDA expansion (+48%), meaningful visit and clinician productivity gains, upgraded full-year guidance and positive clinical outcomes. Key investments in technology, AI and a planned EHR transition support long-term margin objectives, and specialty services are accelerating. Near-term headwinds include modest per-visit revenue growth (TRPV +3%), a modest G&A increase for strategic investments, implementation risk from a multi-year EHR rollout, and no immediate measurable improvement in clinician retention. Overall, the positive growth, profitability, cash generation, and upgraded guidance significantly outweigh the highlighted challenges.Company Guidance
Strong Top-Line Growth
Revenue grew 21% year-over-year to $403M in Q1 2026, driven by higher visit volumes and better-than-expected total revenue per visit.
Significant Adjusted EBITDA Expansion
Adjusted EBITDA increased 48% year-over-year to $51M in Q1 2026, with an adjusted EBITDA margin of 12.7% for the quarter and a raised full-year adjusted EBITDA guidance of $200M–$220M (midpoint implying 12.7% margin and >150 bps margin expansion YoY).
Visit and Clinician Productivity Gains
Visit volumes rose 18% to 2.5M; visits per average clinician increased 7% YoY for the second consecutive quarter, reflecting sustained productivity initiatives.
Clinician Base Expansion
Net clinician adds of 309 in the quarter brought the clinician base to 8,349 (11% growth YoY), supporting capacity and network scale.
Center Margin and Profitability Improvements
Center Margin grew 24% to $136M and represented 33.7% of revenue, benefiting from rate, operating leverage from volume and favorable center spending.
Improved Net Income and Cash Generation
Net income was positive $14M vs $1M a year ago; free cash flow of $22M improved by $32M YoY. Cash balance ended at $195M with net long-term debt $263M and net leverage 0.5x (gross leverage 1.6x).
Raised Full-Year Guidance and Long-Term Targets
Raised 2026 revenue range midpoint to $1.66B (implying ~17% growth), raised Center Margin and adjusted EBITDA guidance, and reaffirmed mid-teens annual revenue growth longer-term and mid-teens adjusted EBITDA margins by 2028.
Clinical Outcomes and Patient Satisfaction
Published outcomes from ~180,000 patients showing roughly 75% experienced clinically significant improvements in anxiety and depression; patient satisfaction strong with a >4.7/5 Google rating across ~575 centers.
Technology & AI Adoption Driving Operational Improvements
Deployment of digital and AI tools (digital check-in, AI-driven workflows, AI-assisted documentation, AI scheduling) and rollout of Care Matching 2.0 improved inbound-to-booking conversion by ~5%; selected a new EHR vendor with implementation planning starting this year and transition in 2027.
Geographic Expansion and Specialty Service Growth
Opened 6 centers and completed 2 tuck-in acquisitions in Q1; company plans 20–30 new centers in 2026. Specialty revenue expected to grow from ~$50M last year to ~$70M in 2026 (~40% YoY), driven by TMS and Spravato expansion.
Capital Allocation and Share Repurchase Activity
Board authorized $100M share repurchase program; $49M deployed in Q1, reflecting confidence in cash generation and capital allocation priorities.
LFST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LFST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 25, 2026 | $7.14 | $7.41 | +3.78% |
Nov 06, 2025 | $4.81 | $6.25 | +29.94% |
Aug 07, 2025 | $3.90 | $3.86 | -1.03% |
May 07, 2025 | $6.55 | $5.51 | -15.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lifestance Health Group (LFST) report earnings?
Lifestance Health Group (LFST) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is Lifestance Health Group (LFST) earnings time?
Lifestance Health Group (LFST) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFST EPS forecast?
LFST EPS forecast for the fiscal quarter 2026 (Q2) is 0.02.